FDA Has Approved Tafenoquine for Treatment of Recurring Malaria

放大字体  缩小字体 Release Date:2018-07-24 Source:bbc news Views:71

FDA Has Approved Tafenoquine for Treatment of Recurring Malaria


Recurring malaria is the most common type of malaria outside Sub-Saharan Africa.


Children can be particularly at risk, getting several bouts of malaria from a single bite, missing lots of school and getting weaker each time they get the disease.


And infected people can act as unwitting reservoirs of the disease because when the parasite reawakens in their bodies a mosquito can carry that parasite on to someone else.


This can make it hard to eliminate around the world.


Now the Food and Drug Administration (FDA) in the United States has given the seal of approval to tafenoquine, a drug that can flush the parasite out of its hiding place in the liver and stop people getting it again.


If news content on our website has infringed your copy right, please contact us! By the meantime all are welcome to contribute your articles here.

Weekly hot news

News recommended

Topics recommended